PURPOSE: The purpose of this study is to assess the feasibility of targeted treatment for pulmonary mucoepidermoid carcinoma (PMEC) by investigating track record of the epidermal growth factor receptor (EGFR) mutation status in PMEC. METHODS: From January 2001 to December 2009, 20 PMEC patients (11 males and 9 females) received treatment in our center. All the patients received surgery and were diagnosed by pathology. Sequencing analysis was used to monitor exons 18-21 of the EGFR gene mutation. RESULTS: The exon 21 L861Q heterozygous mutation was confirmed in five patients. There was no case with any deletion in exon 19 or exon 21 L858R mutation. One case was with a homonymy exon 18 mutation (I760I). Exon 20 G2607A (Q787Q) SNP was found in 12 of those 20 patients. CONCLUSION: L861Q mutation in exon 21 is the most frequent feature of heterozygous mutation in our study. Further investigations will be required to validate our findings.
PURPOSE: The purpose of this study is to assess the feasibility of targeted treatment for pulmonary mucoepidermoid carcinoma (PMEC) by investigating track record of the epidermal growth factor receptor (EGFR) mutation status in PMEC. METHODS: From January 2001 to December 2009, 20 PMEC patients (11 males and 9 females) received treatment in our center. All the patients received surgery and were diagnosed by pathology. Sequencing analysis was used to monitor exons 18-21 of the EGFR gene mutation. RESULTS: The exon 21 L861Q heterozygous mutation was confirmed in five patients. There was no case with any deletion in exon 19 or exon 21 L858R mutation. One case was with a homonymy exon 18 mutation (I760I). Exon 20 G2607A (Q787Q) SNP was found in 12 of those 20 patients. CONCLUSION:L861Q mutation in exon 21 is the most frequent feature of heterozygous mutation in our study. Further investigations will be required to validate our findings.
Authors: Du-Young Kang; Yoo Sang Yoon; Hong Kwan Kim; Yong Soo Choi; Kwhanmien Kim; Young Mog Shim; Jhingook Kim Journal: Lung Cancer Date: 2010-09-29 Impact factor: 5.705
Authors: Yamilet Tirado; Michelle D Williams; Ehab Y Hanna; Frederic J Kaye; John G Batsakis; Adel K El-Naggar Journal: Genes Chromosomes Cancer Date: 2007-07 Impact factor: 5.006
Authors: Stefan Hartmann; Norbert Neckel; Axel Seher; Grit Mutzbauer; Roman C Brands; Christian Linz; Alexander C Kübler; Urs D A Müller-Richter Journal: Clin Oral Investig Date: 2015-08-23 Impact factor: 3.573
Authors: Donna M Graham; Kate M O'Connor; John Hinchion; Linda E Coate; Louise Burke; Derek G Power Journal: Rep Pract Oncol Radiother Date: 2013-08-07
Authors: Sergio Jaramillo; Yesenia Rojas; Bethany J Slater; Michael L Baker; M John Hicks; Jodi A Muscal; Timothy J Vece; David E Wesson; Jed G Nuchtern Journal: Pediatr Surg Int Date: 2016-01-20 Impact factor: 1.827
Authors: Kevin G Neill; James Saller; Sameer Al Diffalha; Barbara A Centeno; Mokenge P Malafa; Domenico Coppola Journal: Cancer Genomics Proteomics Date: 2018 May-Jun Impact factor: 4.069
Authors: Xuanguang Li; Zhibin Guo; Jinghao Liu; Sen Wei; Dian Ren; Gang Chen; Song Xu; Jun Chen Journal: Thorac Cancer Date: 2017-11-28 Impact factor: 3.500